This study demonstrated that resistin treatment could induce NLRP3 expression in human CRC HCT-116 and DLD-1 cells; on the contrary, the inhibition of NLRP3 expression could reduce the 5-FU-induced cytotoxic effect on CRC cells. The gene discussed is NLRP3; the disease is colorectal carcinoma.